Skip to main content
Novavax, Inc. (NVAX)
NASDAQ: NVAX · IEX Real-Time Price · USD
15.03
-0.22 (-1.44%)
At close: May 31, 2024, 4:00 PM
15.08
+0.05 (0.33%)
After-hours: May 31, 2024, 7:59 PM EDT

Novavax Market Cap

Novavax has a market cap or net worth of $2.11 billion as of May 31, 2024. Its market cap has increased by 235.39% in one year.

Market Cap
2.11B
Enterprise Value
1.85B
1-Year Change
235.39%
Ranking
#1884
Category
Mid-Cap
Stock Price
$15.03

Market Cap Chart

Since December 1, 1998, Novavax's market cap has increased from $25.70M to $2.11B, an increase of 8,111.18%. That is a compound annual growth rate of 18.86%.

History

DateMarket Cap% Change
May 31, 20242.11B-1.44%
May 30, 20242.14B0.93%
May 29, 20242.12B-2.61%
May 28, 20242.18B0.10%
May 24, 20242.18B2.31%
May 23, 20242.13B-3.50%
May 22, 20242.20B5.30%
May 21, 20242.09B0.81%
May 20, 20242.08B13.68%
May 17, 20241.83B-9.65%
May 16, 20242.02B11.63%
May 15, 20241.81B-4.30%
May 14, 20241.89B2.82%
May 13, 20241.84B47.63%
May 10, 20241.25B99.30%
May 9, 2024625.60M-
May 8, 2024625.60M-3.04%
May 7, 2024645.20M-3.15%
May 6, 2024666.20M-3.45%
May 3, 2024690.00M4.67%
May 2, 2024659.20M0.86%
May 1, 2024653.60M7.85%
Apr 30, 2024606.00M0.93%
Apr 29, 2024600.40M4.89%
Apr 26, 2024572.40M3.55%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Deciphera Pharmaceuticals 2.21B
Arvinas 2.21B
ADMA Biologics 2.20B
Patterson Companies 2.17B
Fortrea Holdings 2.16B
Intellia Therapeutics 2.13B
Agios Pharmaceuticals 2.13B
LifeStance Health Group 2.13B
Market Cap Rankings